Have a personal or library account? Click to login
A fatal case of acute hemolytic transfusion reaction caused by anti-Wra: case report and review of the literature Cover

A fatal case of acute hemolytic transfusion reaction caused by anti-Wra: case report and review of the literature

Paid access
|Mar 2021

References

  1. Lubenko A, Contreras M. The incidence of hemolytic disease of the newborn attributable to anti-Wra. Transfusion 1992;32: 87–8.
  2. Holman CA. A new rare human blood-group antigen (Wra). Lancet 1953;2:119–20.
  3. Bahri T, de Bruyn K, Leys R, Weerkamp F. Fatal acute hemolytic transfusion reaction due to anti-Wra. Transfus Med Hemother 2018;45:438–41.
  4. Boctor FN. Overt immediate hemolytic transfusion reaction attributable to anti-Wra. Immunohematology 2008;24:113–5.
  5. Cherian G, Search S, Thomas E, Poole J, Davies SV, Massey E. An acute haemolytic transfusion reaction caused by anti-Wra. Transfus Med 2007;17:312–4.
  6. Arriaga F, Palau J, Lopez F, et al. Anti-Wra in newborn twins. Transfusion 1991;31:381–2.
  7. Squires A, Nasef N, Lin Y, et al. Hemolytic disease of the newborn caused by anti-Wright (anti-Wra): case report and review of the literature. Neonatal Netw 2012;31:69–80.
  8. Bunting-Lewis K, Ebbs A. Transfusion reaction caused by anti-Wra in a unit issued by electronic crossmatch. Transfus Med 2005;15(Suppl1):55.
  9. Keutgens A, Monfort M, Wagemans D, Van Cauwenberge JR, Gérard C. Clinical case of the month: mild hemolytic disease of the newborn to an anti-Wra antibody [in French]. Rev Med Liege 2012;67:403–6.
  10. Jørgensen J, Jacobsen L. Erythroblastosis fetalis caused by anti-Wra (Wright). Vox Sang 1974;27:478–9.
  11. Daw E. Haemolytic disease of the newborn due to the Wright antigen. J Obstet Gynaecol Br Commonw 1971;78:377–8.
  12. Metaxas MN, Metaxas-Bühler M. Studies on the Wright blood group system. Vox Sang 1963;8:707–16.
  13. Wallis JP, Hedley GP, Charlton D, Parker PC, Scott Y, Chapman CE. The incidence of anti-Wra and Wra antigen in blood donors and hospital patients. Transfus Med 1996;6:361–4.
  14. Garratty G. How concerned should we be about missing antibodies to low incidence antigens? Transfusion 2003;43: 844–7.
  15. Coluzzi S, De Nicolò MC, Quattrocchi L, Neri A, Ferruzzi I, Girelli G. Should pre-transfusion screening RBC panels contain Wr(a+) cells? Transfus Med 2010;20:337–40.
  16. Kornstad L. Some observations on the Wright blood group system. Vox Sang 1961;6:129–35.
  17. Arriaga F, Llopis F, de la Rubia J, Carpio N, Moscardó J, Marty ML. Incidence of Wra antigen and anti-Wra in a Spanish population. Immunohematology 2005;45:1324–6.
  18. Muniz JG, Arnoni CP, Gazito D, et al. Frequency of Wra antigen and anti-Wra in Brazilian blood donors. Rev Bras Hematol Hemoter 2015;37:316–9.
  19. Greendyke RM, Banzhaf JC. Occurrence of anti-Wra in blood donors and in selected patient groups, with a note on the incidence of the Wra antigen. Transfusion 1977;17:621–4.
  20. Liotta I, Purpura M, Dawes BJ, Giles CM. Some data on the low frequency antigens Wra and BPa. Vox Sang 1970;19:540–3.
  21. Issitt PD, Anstee DJ. Applied blood group serology. 4th ed. Durham, NC: Montgomery Scientific Publications, 1998.
  22. Coghlan G. Antibodies to low-incidence antigens. Transfus Apher Sci 2009;40:199–202.
  23. Hoffmann JJML. Anti-Wra: to screen or not to screen? Transfusion 2007;47:948–9.
  24. Schonewille H, van Zijl AM, Wijermans PW. The importance of antibodies against low-incidence RBC antigens in complete and abbreviated cross-matching. Transfusion 2003;43: 939–41.
  25. Bolton-Maggs PHB. SHOT conference report 2016: serious hazards of transfusion: human factors continue to cause most transfusion-related incidents. Transfus Med 2016;26:401–5.
  26. Serious hazards of transfusion, SHOT. Report, summary and supplement 2017. Available from /https://www.shotuk.org/shot-reports/report-summary-and-supplement-2017/. Accessed August 2020.
  27. Serious hazards of transfusion, SHOT. Report, summary and supplement 2019. Available from https://www.shotuk.org/shot-reports/report-summary-and-supplement-2019/. https://www.shotuk.org/shot-reports/report-summary-and-supplement-2017/. Accessed August 2020.
  28. Norsk hemovigilans, Troll. Rapport: overvåking av blod i Norge [Report: blood monitoring in Norway]. Available from https://www.helsedirektoratet.no/rapporter/overvaking-av-blod-i-norge. Accessed August 2020.
DOI: https://doi.org/10.21307/immunohematology-2021-005 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 20 - 24
Published on: Mar 31, 2021
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2021 A. Espinosa, L.J. Garvik, N. Trung Nguyen, B. Jacobsen, published by American National Red Cross
This work is licensed under the Creative Commons License.